Confirming the normal range for Mebrofenin liver function indices
Kathy P Willowson, Geoff Schembri, Elizabeth A Bailey, Andrew Markewycz, Vivian Chan, Andrew Cluff, Heidi Fearnside, Timothy Kwong, Charlotte Yee, Andrew See, Dale L Bailey

TL;DR
This study establishes normal ranges for liver function indices using Mebrofenin scans and finds no significant age-related differences in these measures.
Contribution
The paper provides empirically derived normal ranges and uncertainty estimates for Mebrofenin-based liver function indices.
Findings
Normal ranges for MURBSA were established as 8.0±1.5 %/min/m2 with a lower limit of 5.1 %/min/m2.
No significant correlation between liver function indices and age was found.
Intra-user variability was measured to assess uncertainty in clinical measurements.
Abstract
To establish normal ranges for [99mTc] Tc-Mebrofenin hepatobiliary scintigraphy (HBS) indices of liver function and the associated uncertainty in clinical measures due to region placement. 47 patients referred for gallbladder assessment with no history of liver disease were included in the study. Patients underwent dynamic HBS following injection of 200 MBq of [99mTc] Tc-Mebrofenin at 10 seconds/frame for 36 frames. Analysis was performed by 5 experienced technologists using in-house software (MIM Software, Cleveland, Ohio) to establish blood pool (BP) clearance rate (%/min), blood clearance half-time (min), mebrofenin liver uptake rate (MUR) (%/min) and MUR normalised to body-surface-area (MURBSA) (%/min/m2). Limits of normal ranges (95%) were established and correlation of functional indices with age was investigated. Analysis was repeated after a minimum of 4 weeks to establish…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLiver Diseases and Immunity · Hepatocellular Carcinoma Treatment and Prognosis · Gallbladder and Bile Duct Disorders
